Japa Associates Inc

After 25 years at large and small pharma, I discovered something: The best clinical teams weren't using expensive CTMS systems. They were using smart Excel dashboards. At PDL BioPharma, I managed 4 simultaneous $26 global trials. We had no CTMS. So I built Excel dashboards that gave real-time visibility into enrollment, budgets, CRO performance, and site metrics. Result? Cut reporting overhead by 40% and caught problems months earlier. That system has become my template at every company since. Are you a biotech running 1-10 trials? Mountains of data in CTMS/EDC systems. But when your board asks,"What's our enrollment velocity?" or investors ask,"How's your CRO performing?"—you're scrambling. You can't afford a $200K head of clinical intelligence. You don't need a full analytics department. But you DO need real-time visibility. That's where I come in. Consider- Dashboard-as-a-Service: Custom dashboards (Excel-based, Power BI at scale) for enrollment, budgets, CRO performance, site metrics - Automated Weekly Reporting: Answer board questions instantly - Expert Interpretation: Insights from 30+ years managing $40M+ budgets across 25+ international trials - FDA & Investor Readiness: Clean metrics for inspections and due diligence - CRO Oversight: Performance scorecards that catch issues early We work with biotechs with 1-10 trials, 5-50 employees, and Series A through pre-commercial. Therapeutic areas: Oncology, CNS, Cardio, Infectious Disease & GI. Common pain points: → Board questions you can't answer quickly → Don't know if CRO is performing until too late → Budget variance surprises at month-end → Dreading FDA inspections → Unprepared for investor diligence We have 30+ years clinical ops leadership at J&J Vision, Genentech, Merck, PDL BioPharma having managed $40M budgets, 25+ trials across 25+ countries, Phase 1-4, IND through NDA submissions, 100% FDA audit success Most consultants can give pretty charts. We give interpretation, not just visualization.